Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United KingdomIPO:
31 March 2021Website:
http://www.achillestx.comNext earnings report:
14 November 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 20 Sep 2024 23:55:55 GMTDividend
Analysts recommendations
Institutional Ownership
ACHL Latest News
LONDON, June 12, 2023 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies to treat solid tumors, today announced that the Company will be taking part in the following conferences in June:
If you're a risk taker on the lookout for stocks with 1000% upside potential, you'd have to venture into speculative territory. It is difficult to find analyst ratings with such a high upside potential unless catalysts could propel the stock that high.
What type of business is Achilles Therapeutics?
Achilles Therapeutics plc, a biopharmaceutical company, develops precision T cell therapies to treat solid tumors. Its platform identifies mutations formed early in the development of cancer. The company offers PELEUS, a proprietary AI-powered bioinformatics platform, used to identify clonal neoantigens in a patient. It also develops CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. Achilles Therapeutics Plc was founded in 2016 and is headquartered in London, the United Kingdom.
What sector is Achilles Therapeutics in?
Achilles Therapeutics is in the Healthcare sector
What industry is Achilles Therapeutics in?
Achilles Therapeutics is in the Biotechnology industry
What country is Achilles Therapeutics from?
Achilles Therapeutics is headquartered in United Kingdom
When did Achilles Therapeutics go public?
Achilles Therapeutics initial public offering (IPO) was on 31 March 2021
What is Achilles Therapeutics website?
https://www.achillestx.com
Is Achilles Therapeutics in the S&P 500?
No, Achilles Therapeutics is not included in the S&P 500 index
Is Achilles Therapeutics in the NASDAQ 100?
No, Achilles Therapeutics is not included in the NASDAQ 100 index
Is Achilles Therapeutics in the Dow Jones?
No, Achilles Therapeutics is not included in the Dow Jones index
When was Achilles Therapeutics the previous earnings report?
No data
When does Achilles Therapeutics earnings report?
The next expected earnings date for Achilles Therapeutics is 14 November 2024